Join to View Full Profile
VA Foothill BlvdSalt Lake City, UT 84148
Phone+1 801-582-1565
Fax+1 801-587-7539
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Douglas Ball, MD is a family physician in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah, New Jersey, and New York.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Medical Genetics and Genomics, 2012 - 2014
University of Rochester Medical CenterResidency, Public Health and General Preventive Medicine, 2005 - 2006
University of Texas Southwestern Medical CenterResidency, Radiology-Diagnostic, 1998 - 1999
Houston Methodist Hospital (Medical Center)Residency, Surgery, 1995 - 1998
Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
UT State Medical License 2016 - 2026
TX State Medical License 1997 - 2025
NJ State Medical License 2006 - 2019
NY State Medical License 2006 - 2017
American Board of Preventive Medicine Public Health & General Preventive Medicine
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- 2 citationsPermitted Daily Exposure Values: Application Considerations in Toxicological Risk Assessments.Douglas J. Ball, William P. Beierschmitt
International Journal of Toxicology. 2020-08-14 - 8 citationsImmunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats - Comparison of juvenile and adult responses.Mark Collinge, Douglas J. Ball, Christopher J. Bowman, Andrea L. Nilson, Zaher A. Radi
Regulatory Toxicology and Pharmacology. 2018-04-01 - 5 citationsCellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.Zaher A. Radi, W. Mark Vogel, Phillip M. Bartholomew, Petra H. Koza-Taylor, Alexandros Papanikolaou
Regulatory Toxicology and Pharmacology. 2017-12-01
